KIDS icon

OrthoPediatrics

23.76 USD
-0.60
2.46%
At close Feb 21, 4:00 PM EST
After hours
23.76
+0.00
0.00%
1 day
-2.46%
5 days
-5.41%
1 month
-12.78%
3 months
-10.24%
6 months
-24.43%
Year to date
3.89%
1 year
-15.57%
5 years
-51.12%
10 years
23.62%
 

About: OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.

Employees: 247

0
Funds holding %
of 7,139 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

657% more call options, than puts

Call options by funds: $53K | Put options by funds: $7K

1.59% less ownership

Funds ownership: 67.54% [Q3] → 65.95% (-1.59%) [Q4]

13% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 39

15% less funds holding

Funds holding: 124 [Q3] → 105 (-19) [Q4]

16% less capital invested

Capital invested by funds: $443M [Q3] → $370M (-$73M) [Q4]

57% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 30

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$25
5%
upside
Avg. target
$34
41%
upside
High target
$42
77%
upside

2 analyst ratings

positive
50%
neutral
50%
negative
0%
Needham
Mike Matson
55% 1-year accuracy
67 / 122 met price target
77%upside
$42
Buy
Reiterated
14 Jan 2025
Truist Securities
Richard Newitter
77% 1-year accuracy
33 / 43 met price target
5%upside
$25
Hold
Maintained
18 Dec 2024

Financial journalist opinion

Neutral
GlobeNewsWire
3 days ago
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
WARSAW, Ind., Feb. 19, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, March 4, 2025 at 4:30 p.m. ET to discuss the results.
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company gained distribution rights to bring additional bracing solutions to the US market through its OrthoPediatrics Specialty Bracing (OPSB) division.
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance
Achieves all-time high full year 2024 Revenue of $205 million representing growth of 38% Year-Over-YearInitiates guidance for record adjusted EBITDA in 2025
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division
WARSAW, Ind., Jan. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the rapid expansion of its Specialty Bracing (OPSB) division with entrance into 3 target markets within Indiana, Colorado, and Florida.
OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division
Neutral
GlobeNewsWire
2 months ago
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products
WARSAW, Ind., Dec. 05, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics today announced that the OrthoPediatrics Specialty Bracing (OPSB™) division is expanding its product offering with the launch of two new products including the OPSB Sensor System and MOVE-D™.
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products
Neutral
GlobeNewsWire
2 months ago
OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)
WARSAW, Ind., Dec. 02, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced plans to host educational and networking events at IPOS and its continued support of the event as an Emerald-Level sponsor.
OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)
Neutral
GlobeNewsWire
2 months ago
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2® Brace
WARSAW, Ind., Nov. 26, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company dedicated exclusively to advancing the field of pediatric orthopedics, is excited to announce significant updates to the DF2® Brace, a cornerstone product within the OrthoPediatrics Specialty Bracing business (“OPSB”). The DF2 Brace updates include expanded indications for use, enhanced sizing options, and additional international markets.
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2® Brace
Neutral
Seeking Alpha
3 months ago
OrthoPediatrics Corp. (KIDS) Q3 2024 Earnings Call Transcript
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Trip Taylor - Gilmartin Group David Bailey - President & Chief Executive Officer Fred Hite - Chief Financial Officer & Chief Operating Officer Conference Call Participants Matt O'Brien - Piper Sandler Joseph Conway - Needham & Company Operator Good morning and welcome to OrthoPediatrics Corporation's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
OrthoPediatrics Corp. (KIDS) Q3 2024 Earnings Call Transcript
Positive
Zacks Investment Research
3 months ago
Compared to Estimates, OrthoPediatrics (KIDS) Q3 Earnings: A Look at Key Metrics
The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, OrthoPediatrics (KIDS) Q3 Earnings: A Look at Key Metrics
Negative
Zacks Investment Research
3 months ago
OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.13 per share a year ago.
OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates
Charts implemented using Lightweight Charts™